Scotland · NHS Scotland MSAN
Sancuso® (granisetron) 3.1mg/24 hours transdermal
MSAN(2021)7 · Level 2 · issued 08 Mar 2021
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Sancuso® (granisetron) 3.1mg/24 hours transdermal patches are out of stock until late March | Out of stock | late March |
| 3. An alternative 5HT3 antagonist, ondansetron, is available in formulations suitable for patients | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2021:7
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
eede01d4701e865305cdd173d86f53e3e527cbf3d455282ae6689fba10fd0dafsha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2021-07.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.